Reuters Health Report

If you are having trouble viewing this email or would like to view it in your web browser, CLICK HERE

Good Morning Postlinuxeg, FRI 11 Jun 2010 
 
House panel cites J&J response in recall probe
Drugmakers to share data to speed brain drug research
FDA warns Pfizer for not reporting side effects
Faulty gene leads to protein buildup in Alzheimer's
Democrats launch push to promote Obama health law
Customs group to fight $200 bln bogus drug industry
Sickened September 11 workers get revised settlement
Free drugs may help more get chlamydia treatment
Cheap gout drug shows promise in kidney disease
Moms' full-time work tied to childhood obesity

House panel cites J&J response in recall probe
June 11, 2010 09:09 AM ET
NEW YORK (Reuters) - A U.S. Congressional committee investigating the recent recall of Johnson & Johnson's children's medicine is "deeply concerned" about the manufacturer's cooperation, a committee spokeswoman said on Friday.

Full Article
Drugmakers to share data to speed brain drug research
June 11, 2010 12:07 AM ET
WASHINGTON (Reuters) - Major drugmakers will share data from their clinical trials for Alzheimer's and Parkinson's disease in an effort to speed the development of new medicines to treat the brain disorders.

Full Article
FDA warns Pfizer for not reporting side effects
June 10, 2010 06:59 AM ET
WASHINGTON (Reuters) - The U.S. Food and Drug Administration has warned Pfizer Inc for failing to quickly report serious and unexpected potential side effects from its drugs already on the market.

Full Article
Faulty gene leads to protein buildup in Alzheimer's
June 10, 2010 06:06 PM ET
CHICAGO (Reuters) - A brain mechanism that acts like a recycling plant for toxic proteins goes haywire in people with a gene mutation linked with Alzheimer's disease, U.S. researchers said on Thursday, unveiling a discovery offering a new lead for drug companies.

Full Article
Democrats launch push to promote Obama health law
June 10, 2010 04:54 PM ET
WASHINGTON (Reuters) - Democrats launched a new push on Thursday to promote U.S. President Barack Obama's healthcare overhaul, as the first $250 rebates were mailed to seniors to help plug gaps in Medicare prescription drug coverage.

Full Article
Customs group to fight $200 bln bogus drug industry
June 10, 2010 06:04 PM ET
PARIS (Reuters) - Counterfeit drugs have become a $200-billion-a-year industry and the 176-nation World Customs Organization (WCO) will sign a declaration later this month to fight the scourge, an official said on Thursday.

Full Article
Sickened September 11 workers get revised settlement
June 10, 2010 05:08 PM ET
NEW YORK (Reuters) - Attorneys for thousands of workers who suffered health problems stemming from the September 11, 2001, attack on the World Trade Center reached a revised $712 million settlement with New York City on Thursday.

Full Article
Free drugs may help more get chlamydia treatment
June 10, 2010 04:20 PM ET
NEW YORK (Reuters Health) - Vouchers for free medication might help the sexual partners of people being treated for chlamydia get treatment too, a new study says.

Full Article
Cheap gout drug shows promise in kidney disease
June 10, 2010 05:07 PM ET
LONDON (Reuters) - A drug commonly used to treat gout may help patients with chronic kidney disease keep their condition in check and reduce the risk of heart problems, Spanish scientists said on Thursday.

Full Article
Moms' full-time work tied to childhood obesity
June 10, 2010 04:17 PM ET
NEW YORK (Reuters Health) - The growing number of full-time working moms in the past few decades could be one of the factors contributing to the concurrent rise in childhood obesity, new research hints.

Full Article
 
 











REUTERS www.reuters.com
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book.Details
Subscribe to other Reuters newsletters
Unsubscribe from this newsletter.


Forward to a friend Send this mailing to a friend or colleague


Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS RSS Feed | Interactive TV | Labs | Reuters in Second Life | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

0 comentários: